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Renal function before and after hemorrhage in rats with chronic bile
duct obstruction: A micropuncture study. Marjorie E. M. Allison. N.
E. Moss, Mary Fraser, C. Ryan, J. W. Dobbie, A. C. Kennedy and
L. H. Blumgart. University Departments of Medicine and Surgery,
Royal Infirmary. Glasgow, Scotland. In accordance with observa-
tions on patients, Dawson (Br MedJ 1:810-811, 1964) found that in
rats with biliary tract obstruction renal ischemia was consistently
followed by severe acute renal failure. We have used micropuncture
and light and electron microscopy techniques to study single neph-
ron and whole kidney structure and function before and immediate-
ly after hemorrhagic shock in rats with chronic bile duct obstruc-
tion (CBDO) and in sham-operated control rats (C). In vivo CBDO
rat kidneys appeared abnormal, with deposition of pigment
throughout the renal tubule cells and with intratubular debris and
pigment. Urine flow rate, sodium excretion, whole kidney glomeru-
lar filtration rate (GFR), superficial single nephron filtration rate
(SNGRF), glomerular capillary hydrostatic pressure and proximal
fractional reabsorption were not significantly different in the two
groups before hemorrhage. Renal plasma flow (RPF), however, was
significantly increased and filtration fraction significantly decreased
in CBDO. Free-flow proximal intratubular hydrostatic pressure var-
ied in CBDO rats (6 to 34 mm Hg), high pressures presumably
being due to distal intratubular block. Hemorrhage to 30 mm Hg
for 30 mm and retransfusion resulted in a significant diuresis and
natriuresis, more marked in C rats, but without a significant change
in blood pressure or hematocrit. SNGRF fell significantly in both
groups, but expecially in the jaundiced animals where there was also
a parallel fall in GRF and RPF. No change in proximal fractional
reabsorption was found. Hence, factors operating beyond the proxi-
mal tubule must be important in the diuretic response. We conclude
that CBDO in the rat results in structural changes and subtle altera-
tion in renal function with evidence of tubular obstruction and that
the response to hemorrhage is attenuated in these animals.
Mesangial cell phagocytic function in renal diseases. George Drivas
and Nigel Wardle. Royal Victoria Infirmary, Newcastle upon Tyne,
England. There are many indications that the mesangial cells of the
renal glomeruli have a phagocytic function and that this is relevant
to the understanding of renal diseases. Our initial studies were per-
formed in animals in which we analyzed the role of the mesangial
cell in serum sickness nephritis and in experimental diabetes mel-
litus induced by streptozotocin. The technique was the clearance of
radio-iodinated human gamma-globulin as used by Mauer et al (J
Clin Pathol 26:198; 1973). rn the case of horse serum nephritis it was
possible to show that mesangial cell saturation occurred when a
heavy load of immune complexes was present in the circulation. If
this occurs in human disease or if the mesangial cells are otherwise
damaged (for example by antibodies), then this will explain how im-
mune complexes accumulate in or above the basement membrane.
Even early in experimental diabetes, long before changes of diabetic
nephropathy were present, it was found that the mesangial cells have
an impaired phagocytic capacity. This is likely to reflect a metabolic
defect. Moreover, it could explain why in diabetic nephropathy lip-
oproteins, fibrinogen and other serum proteins accumulate as "fibri-
noid" in the renal glomeruli. We then turned to human investigation
using the whole body RES clearance of aggregated 125 iodinated Ilu-
man serum albumin and have so far investigated patients with im-
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munosuppression in the course of renal transplant management and
also patients with different types of nephritis.
Adaptations in nitrogen metabolism in acidosis in man. A. Fine, E.
Carlyle and E. Bourke. Tenovus Kidney Diseases Research Unit,
Royal Infirmary, Glasgow, Scotland; and Department of Clinical
Medicine. Trinity College, Dublin. Ireland. In acidosis, enhanced
renal ammoniagenesis represents the body's most important home-
ostatic response. The renal production of ammonia (NH3) from
glutamine "mops up" H+ (from intracellular carbonic anhydrase) to
be excreted as NH4+. This concept ignores possible adaptations in
the body's N balance but more significantly is simplistic in that it
derives from the practice of writing the formulae of the reactants in
unionized form. However, glutamine is a zwitterion and gives rise to
NH4+ directly and cannot "mop up" H+. An alternative explanation
is required. NH4CI acidosis is conventionally ascribed to dis-
sociation into NH3 (—. urea) and HCI. However, it dissociates into
NH4+ and C1 so an alternative explanation for the resultant acid-
osis is required. In this respect urea synthesis utilizes 2HC03. Urea
or NH4+ formation results in the production of 2-oxo-glutarate.
Its subsequent metabolism (complete oxidation or to glucose forma-
tion) yields 2HCO3 The urea cycle is balanced; in the kidney there
is a net gain in HC03. The effects of 200 mEq of HCI, NH4CI and
NH4HCO3 administered orally to four healthy volunteers were
studied. With HCI acidosis, blood urea fell significantly (P < 0.025),
total urinary N (urea + NH4 was reduced (P < 0.05) and there was
a correlation between increased NH4+ excretion and reduced urea
excretion (r = 0.87, P < 0.01). Urea formation was significantly
greater after NI-14HC03 than after NH4CI (P < 0.005). These re-
sults concur with the above interpretation. In HCI acidosis, waste N
is diverted from urea production (HCO3utilizing) to NFL4 (HCO3
regenerating). With NH4HCO3, each NH4 entering the urea cycle
is balanced by HCO3 in the salt so that there is no alteration in
acid-base balance and urea production increases. With NH4CI, be-
cause of added NH , onlyone -ye charge is produced by urea for-
mation, so that onlg one HCO3 is subsequently produced. As urea
production utilizes 2HC03, acidosis ensues and waste N is diverted
to urinary NH4 as seen with HCI.
Interrelationships between plasma and cerebrospinal fluid amino acid
composition in normal individuals and patients with renal disease. E.
H. F. McGale, I. F. Pyc, E. C. Hut chinson, J. M. Massey and G. M.
A ber. Renal and Neurological Research Laboratories, Medical Re-
search Unit. North Staffordshire Hospital Centre. Hartshill. Stoke-
on-Trent, England. The concentration of amino acids in simulta-
neously sampled plasma and cerebrospinal fluid (CSF) has been
measured in 42 normal subjects and in 14 patients with "steady
state" renal disease. The findings have been compared with similar
studies in nine patients following intermittent hemodialysis in order
to establish the influence of changes in plasma amino acid concen-
tration in patients with renal failure on the CSF amino acid compo-
sition. In all studies the dietary intake of protein has been con-
trolled. The effect of rapid changes in plasma amino acid
concentrations on the CSF amino acid profile has also been exam-
ined in similar groups of patients. The results demonstrate the fol-
lowing: 1) CSF is not a plasma ultrafiltrate with respect to its amino






acid composition. 2) Differences between CSF and plasma amino
acid composition with relationship to age and sex have been found.
3) The CSF amino acid profile in patients with renal failure is signif-
icantly different from normal. This cannot be accounted for entirely
by changes in the concentration of plasma amino acids. 4) Changes
in plasma amino acid concentrations induced by hemodialysis are
not reflected in the CSF. 5) As yet, unidentified amino compounds
are present in the CSF of patients with renal failure which are not
present in their plasma or in the plasma and CSF of normal individ-
uals.
Uric acid transport in the pig kidney. H. A. Simmonds. P. J. Hat-
field, A. Cadenhead and J. S. Cameron. Guy's Hospital Medical
School, London and the Rowett Research Institute, Bucksburn, Ab-
erdeen, England. Recently, ideas on the renal handling of urate have
been challenged. The traditional view has been that urate is freely
filterable at the glomerulus, and then undergoes bidirectional trans-
port in the renal tubule. Reabsorption has been thought to occur in
the proximal tubule, followed by more distal secretion; the result in
man is net reabsorption. The site and extent of these two opposing
transport systems now appear to vary in different species. In man,
the uricosuric drug probenecid has been considered to inhibit proxi-
mal reabsorption, and the antituberculous drug pyrazinamide to in-
hibit secretion. After pyrazinamide treatment in man, the urine be-
comes essentially free of urate. This has provided the basis for a
hypothesis that reabsorption or urate is almost complete, the much
smaller secretory component being responsible for excreted urate.
However, recent experiments in chimpanzees and monkeys have
questioned the validity of this "pyrazinamide suppression test"
which has been widely used to evaluate renal urate handling in both
gout and renal failure. We have already carried Out experiments in
pigs which have demonstrated that there is a greater similarity be-
tween purine metabolism and renal function in this species than
most other laboratory animals. In particular, the pig kidney cannot
generate uric acid in situ, as can many species. Despite this, urate
transport in the pig kidney has not been examined. For those rea-
sons, we have investigated the handling of urate by the pig kidney, as
well as studied the effects of probenecid and pyrazinamide in this
species. Since pigs (like most nonprimates) break down uric acid
and excrete the end product of their purine metabolism as allantoin,
it is necessary to infuse uric acid. In these studies, there was net se-
cretion of uric acid at all measurable plasma urate concentrations.
Probenecid inhibited urate secretion in a dose-dependent fashion,
but even the highest infusion rates of the drug did not result in
Curate/CinuIin ratios of less than 1.0. Neither pyrazinamide nor its
active metabolite pyrazinoic acid had any apparent effect upon
urate secretion, but at high infusion rates pyrazinoic acid was a po-
tent diuretic. Probenecid was still able to exert an effect in reducing
the secretion of urate in the presence of pyrazinamide. An inter-
esting observation was that high urate infusion rates produced a re-
duction in glomerular filtration rate, and one pig went into acute
renal failure. These studies suggest that the pig's renal tubules are
incapable of reabsorbing filtered urate, and that it therefore handles
urate as a foreign organic acid which it eliminates by filtration and
secretion. These results throw further doubt on the validity of the
pyrazinamide suppression test as it is currently interpreted.
Urinary gamma-glutamyl transpeptidase, an indicator of renal is-
chemic injury and honiograft rejection. J. P. Ward. St. Bartholo-
mew's Hospital, London, England. Gamma-glutamyl trans-
peptidase (gamma-GT) is an enzyme primarily located in the brush
border of the proximal convoluted tubule of the kidney. Its unique
localization in the renal cells most easily damaged by ischemia and
its ease of assay, provide the rationale for its use in the measurement
of renal ischemic injury. The determination and evaluation of -GT
activity in plasma and urine in experimental canine renal ischemia
and following human renal homotranspiantation forms the basis of
this paper. Using a standard experimental model, 67 dogs under-
went periods of renal ischemia, induced by clamping of the left renal
artery, varying from 5 to 90 mm with one group of dogs as controls.
Urinary and plasma -GT estimations were undertaken using a
simple, one-step photometric color reaction devised by Szasz requir-
ing no incubation. A prospective study of 20 consecutive patients
undergoing renal homotransplantation using both cadaver and liv-
ing related donors was performed and daily 24-hr urine 'y-GT esti-
mations were undertaken from the day of the transplant for up toSS
days. Control human 24-hr urinary -GT estimations were obtained
from ten healthy men and ten men with no renal disease but who
were receiving prednisone therapy. Over 2,000 'y-GT estimations
were performed and statistical analysis of the results was under-
taken. Urinary -GT increased 50-fold following 90 mm of unilater-
al artery occlusion in dogs and a significant increase followed 5 mm
ischemia. Plasma 'y-GT was not raised at any time from IS mm to
eight days following renal ischemia. In human homotransplanta-
tion, 'y-GT is released in large quantities following the ischemia of
renal preservation but returns to normal within 24 hr. In homograft
rejection episodes (one component being a vascular ischemic phe-
nomenon), urinary 'y-GT was significantly raised. The upper limit of
normal for 24-hr -GT from a single kidney was 27.6 U and during
frank rejection was more than 60 U. No significant correlation was
noted between the rate of rejection as measured by urinary 'y-GT
and the degree of tissue matching between donor and recipient. The
laboratory test for urinary y-GT activity is simple, quick and in-
expensive, making it a useful test to quantify renal ischemic injury,
particularly when the degree of injury has been small. It is an almost
ideal daily test for monitoring the progress of renal homo-
transplants during the postoperative period as it is an extremely sen-
sitive indicator of transplant rejection. In some instances rejection
can be diagnosed using the urinary 1-GT activity before other clini-
cal and biochemical techniques suggest it.
IgA and glomerular disease. Judith A. Whitworth, S. Leibowitz,
Mary C. Kennedy and J. S. Cameron. Department of Pathology
and Medicine, Guy's Hospital, London, England. Serum IgA is ele-
vated in a proportion of children with Henoch-Schönlein disease
(HSP), in patients with Berger's mesangial IgA disease and in
patients with glomerular lesions in association with hepatic cir-
rhosis. These conditions are all characterized by mesangial staining
with anti-IgA antisera on immunofluorescence. It has been sug-
gested that elevated IgA concentrations are of value in the diagnosis
of these diseases. We have measured IgA concentrations by radial
immunodiffusion in a variety of primary and secondary glomerular
diseases. High serum IgA concentrations were confined to patients
with glomerular IgA deposition, but were not restricted to HSP and
Berger's disease, or to patients with deposition of IgA only in a mes-
angial pattern.
